4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Alpha Tau Medical Ltd. (DRTS) operates in the Biotechnology industry and is headquartered in Jerusalem, Israel with about 121 employees. Its market capitalization is roughly $1 billion. In the fiscal year ended 2025-12-31, DRTS reported $0M in revenue and ($43M) in net income.
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($42M) | ($36M) | ($36M) | ($32M) | — |
| Net Income | ($43M) | ($32M) | ($29M) | ($34M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($13M) | ($13M) | ($11M) | ($10M) | ($9M) |
| Net Income | ($23M) | ($12M) | ($12M) | ($10M) | ($9M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $106M | $86M | $107M | $120M | — |
| Total Liabilities | $29M | $24M | $23M | $14M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive DRTS viewer.
About TickerBase · Data methodology & sources